WHO has issued a press release assuring the world that its lethal “swine flu” vaccine is safe.
This is the same WHO that developed a method to use vaccines to kill people in three steps which were described in memos dated from 1972, discovered by Patrick Jordan and to be seen on Dr Rebecca Carley’s website, www.drcarley.com.
This is the same WHO that has now put that precise theory into practice by producing “swine flu” vaccines that will, in a three-pronged approach,
a) weaken the immune system
b) inject a huge dose of virus into the body, which the weakened immune system cannot fight
c) inject an oil in water adjuvant that will create an inflammatory reaction and a cytokine storm
and so kill
in three steps
in the exact sequence outlined in the 1972 WHO memos.
This is also the same WHO that is allowing the US government to test only vaccines without adjuvants in clinical trials for the “swine flu” vaccine that are currently underway even though the people of the USA will get vaccines with adjuvants scientifically proved to be dangerous.
And this is the very same WHO that unilaterally declared a pandemic level 6 emergency after altering the definition of pandemic several times until it was loose enough to allow it to declare just such an pandemic emergency, allowing it to impose martial law, quarantines and forced vaccinations on the world.
This is the WHO that has instructed governments around the world to start forced mass vaccinations against a harmless “swine flu” that is misdiagnosed 9 times out of 10 and that might not even exist because so far it has never been isolated in a lab.
This is the organisation that refused to release minutes of a key meeting on July 7th when its “vaccine advisory board”, packed with executives from pharmacuetical companies such as Baxter and Novartis as “observers”, recommended to WHO that it order forced vaccinations around the world with their vaccines, ensuring them vast profits.
This is the same WHO that is now in control of health and security services around the world thanks to legislation it imposed in the form of the International Health Regulations 2005, incorporated into national pandemic plans.
This is the WHO that supplied Baxter’s Austrian subsidiary with the live bird flu virus that Baxter used to contaminate 72 kilos of vaccine material before sending it out to 16 labs, so nearly triggering a pandemic this February.
This is the WHO that allegedly investigated Baxter’s violation of every biosafety level 3 regulation at its facility in Austria – and mysteriusly found no problem.
And now this WHO, made “aware of some media reports that have expressed concern about the safety of vaccines for pandemic influenza”, issues a press release to reassure us that the procedures for “expediting regulatory approval” for a toxic vaccine to be administered on a “massive scale” on their orders and for no convincing reason “are rigorous and do not compromise safety or quality controls.”
How rigorous might these expedited regulatory approval procedures be?
By “some media reports”, does WHO mean the countless medical professors that have issued statements saying the swine flu is harmless, will stay harmless and there is absolutely no justification for WHO declaring a pandemic level 6 and implementing forced mass vaccinations? Or do they mean the swelling ranks of media reports that analyse the lethal compoents of the WHO killer vaccine, especially the adjuvants, in detail?
Perhaps they are referring to French bloggers, who are calling WHO “criminal Nazis”?
Or might they be referring to my humble blog where I present more facts and evidence every day of WHO’s plans for genocide by means of forced vaccinations with toxic substance?
“On the positive side, mass vaccination campaigns can generate significant safety data within a few weeks,” trumpets WHO in a press release dated August 6th in the name of the anonymous collective “WHO”.
Perhaps “safety data” refers to how many people are killed, damaged etc by their forced mass vaccination programme with a substance classified by EU and US regulators as a bioweapon.
“International sharing of data from such post-marketing surveillance will be vital in guiding risk-benefit assessments and determining whether changes in vaccination policies are needed,” adds WHO, indicating that they are already considering alternative methods of mass murder if not enough people are shown to have succumbed to their killer vaccine in a “post marketing surveillance”, thereby significantly increasing the risk that they and their backers will end up in goal instead of in control of the world, the presumed benefit from this mass murder.
Why does WHO put so much weight on post marketing surveillance and so little on gathering data on the swine flu today? Why has WHO abandoned reporting requirements on the “swine flu’s” spread?
Read for yourself this press release of WHO as it prepares to launch the biggest genocide by means of forced vaccination in human history.
“War is peace” as the Ministry of “Truth ” declared in George Orwell’s book describing life in a totalitarian system “1984″.
And WHO killer vaccines are “safe”.
http://www.who.int/csr/disease/swineflu/notes/h1n1_safety_vaccines_20090805/en/index.html
Pandemic (H1N1) 2009 briefing note 6
6 AUGUST 2009 | GENEVA — WHO is aware of some media reports that have expressed concern about the safety of vaccines for pandemic influenza. The public needs to be reassured that regulatory procedures in place for the licensing of pandemic vaccines, including procedures for expediting regulatory approval, are rigorous and do not compromise safety or quality controls.
Vaccines are among the most important medical interventions for reducing illness and deaths during a pandemic. However, to have the greatest impact, pandemic vaccines need to be available quickly and in large quantities.
Related links
Pandemic influenza vaccine manufacturing process and timeline
6 August 2009
During the 1957 and 1968 pandemics, vaccines arrived too late to be used as an effective mitigation tool during the more severe phases of the pandemics. Influenza vaccines had not yet been developed when the 1918 pandemic swept around the world, eventually killing an estimated 50 million people.
In 2007, as part of preparedness for an influenza pandemic, WHO worked together with health officials, regulatory authorities, and vaccine manufacturers to explore a broad range of issues surrounding the regulatory approval of pandemic vaccines. [1]
Ways were sought to shorten the time between the emergence of a pandemic virus and the availability of safe and effective vaccines. Different regulatory pathways were assessed, and precautions needed to ensure quality, safety, and effectiveness were set out in detail.
Fast-track procedures for approval
Regulatory authorities have shown great flexibility in developing procedures for fast-tracking the approval and licensing of pandemic vaccines.
In some cases, pandemic vaccines are not regarded by regulatory authorities as entirely “new” vaccines, as they build on the technology used to produce vaccines for seasonal influenza, established procedures for testing and regulatory control, and an extensive body of safety data.
In such cases, approval procedures are similar to those applied to “strain changes” made each year when seasonal vaccines are modified to match circulating viruses in the Northern and Southern Hemispheres.
Specific regulatory procedures have been devised to expedite the approval of pandemic vaccines. In the USA, for example, fewer data are required when the manufacturer already has a licensed influenza vaccine and intends to use the same manufacturing process for its pandemic vaccine.
In the European Union, the European Medicines Agency uses a rolling review procedure whereby manufacturers can submit sets of data for regulatory review as they become available, without having to wait until all data can be submitted together in a single formal application.
Also in Europe, some manufacturers have conducted advance studies using a so-called “mock-up” vaccine. Mock-up vaccines contain an active ingredient for an influenza virus that has not circulated recently in human populations and thus mimics the novelty of a pandemic virus. Such advance studies can greatly expedite regulatory approval.
Special safety concerns
Influenza vaccines have been used for more than 60 years and have an established record of safety in all age groups. While some serious adverse events have been reported, these have been rare.
Nonetheless, special safety issues will inevitably arise during a pandemic when vaccine is administered on a massive scale. For example, adverse events too rare to show up even in a large clinical trial may become apparent when very large numbers of people receive a pandemic vaccine.
Some adverse events will be coincidental – that is, associated in time with vaccine administration, yet not directly caused by the vaccine. Genuine adverse events directly caused by the vaccine may also occur, but cannot be predicted in advance. Given the safety record of seasonal vaccines, such events are expected to be rare.
Time constraints mean that clinical data at the time when pandemic vaccines are first administered will inevitably be limited. Further testing of safety and effectiveness will need to take place after administration of the vaccine has begun.
For these reasons, WHO advises all countries administering pandemic vaccines to conduct intensive monitoring for safety and efficacy, and many countries have plans in place for doing so. On the positive side, mass vaccination campaigns can generate significant safety data within a few weeks.
International sharing of data from such post-marketing surveillance will be vital in guiding risk-benefit assessments and determining whether changes in vaccination policies are needed. WHO has developed standardized protocols for data collection and reporting in real-time, and will communicate findings to the international community via its web site.
_________________________
[1] Regulatory preparedness for human pandemic influenza vaccines. Report of a WHO Expert Committee on Biological Standardization. Geneva: World Health Organization, 2007 [pdf 625kb]
